Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07216924 · ClinicalTrials.gov registry record · NA
Remapping Text in Sentence and Word Tasks to Aid Reading With Central Vision Loss
A NA study, sponsored by University of Minnesota.
- Not yet
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT07216924: Clinical Trial NA study, sponsored by University of Minnesota.
NCT07216924 is a NA study that has not yet begun recruiting, run by University of Minnesota. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07216924, a NA study, has not yet begun recruiting, sponsored by University of Minnesota.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
Reading performance in patients with Central Vision Loss will be measured with and without missing text being remapped to different parts of the visual field in a variety of different reading tasks.
Primary Outcome
Time it took to read sentence in words per minute
Interventions
- BEHAVIORAL Personalised Remapping Training
- BEHAVIORAL RSVP personalized remappi
- BEHAVIORAL Reading text in the wild with remapping
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2027-06 |
| Est. Completion | 2032-05 |
| Phase | NA |
What is known before NCT07216924 opens enrollment
NCT07216924 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 3 interventions - of which Personalised Remapping Training is the first listed.
NCT07216924 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07216924 about?
NCT07216924 is a clinical study titled "Remapping Text in Sentence and Word Tasks to Aid Reading With Central Vision Loss". Reading performance in patients with Central Vision Loss will be measured with and without missing text being remapped to different parts of the visual field in a variety of different reading tasks.
What is the current status of trial NCT07216924?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2027-06. Estimated completion is 2032-05.
What interventions are being tested in trial NCT07216924?
The interventions under investigation include: Personalised Remapping Training (BEHAVIORAL), RSVP personalized remappi (BEHAVIORAL), Reading text in the wild with remapping (BEHAVIORAL).
Who is sponsoring clinical trial NCT07216924?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07216924's enrollment target sits among peer trials
100 840th of 2000 higher than 1,081 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia